In this study we demonstrated that the TMEM219 signaling is active in beta cells at their early stage of maturation and it may serve as a target to unleash regenerative potentials of precursor cells and help to replenish the beta cell mass in disease conditions such as T1D. This evidence concerns the gene TMEM219 and type 1 diabetes mellitus.